apoE isoforms and measures of anxiety in probable AD patients and Apoe−/− mice

[1]  R. Leurs,et al.  Role of H3-Receptor-Mediated Signaling in Anxiety and Cognition in Wild-Type and Apoe–/– Mice , 2004, Neuropsychopharmacology.

[2]  A Hofman,et al.  Hippocampal, amygdalar, and global brain atrophy in different apolipoprotein E genotypes , 2002, Neurology.

[3]  L. Mucke,et al.  Androgens Protect against Apolipoprotein E4-Induced Cognitive Deficits , 2002, The Journal of Neuroscience.

[4]  J. Gugten,et al.  HPA axis dysregulation in mice overexpressing corticotropin releasing hormone , 2002, Biological Psychiatry.

[5]  George Paxinos,et al.  The Mouse Brain in Stereotaxic Coordinates , 2001 .

[6]  G. Schellenberg,et al.  Increased CSF cortisol in AD is a function of APOE genotype , 2001, Neurology.

[7]  L. Gibbons,et al.  Anxiety and Alzheimer's Disease , 2001, Journal of geriatric psychiatry and neurology.

[8]  Jacob Raber,et al.  Hypothalamic–Pituitary–Adrenal Dysfunction inApoe−/− Mice: Possible Role in Behavioral and Metabolic Alterations , 2000, The Journal of Neuroscience.

[9]  W. Kukull,et al.  Anxiety of Alzheimer's disease: prevalence, and comorbidity. , 1999, The journals of gerontology. Series A, Biological sciences and medical sciences.

[10]  L. Mucke,et al.  Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[11]  T. Bliss,et al.  Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse , 1998, Neuroscience.

[12]  Michael Davis,et al.  Double Dissociation between the Involvement of the Bed Nucleus of the Stria Terminalis and the Central Nucleus of the Amygdala in Startle Increases Produced by Conditioned versus Unconditioned Fear , 1997, The Journal of Neuroscience.

[13]  J. Haines,et al.  Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium. , 1997, JAMA.

[14]  J. Haines,et al.  Effects of Age, Sex, and Ethnicity on the Association Between Apolipoprotein E Genotype and Alzheimer Disease: A Meta-analysis , 1997 .

[15]  H Rusinek,et al.  Cortisol reduces hippocampal glucose metabolism in normal elderly, but not in Alzheimer's disease. , 1997, The Journal of clinical endocrinology and metabolism.

[16]  J. Cummings,et al.  The Neuropsychiatric Inventory , 1997, Neurology.

[17]  J. Rozing,et al.  Differences in Dexamethasone-Sensitivity between Lymphocytes from Patients with Alzheimer's Disease and Patients with Multi-Infarct Dementia , 1996, Brain, Behavior, and Immunity.

[18]  H. Soininen,et al.  SPECT and MRI analysis in Alzheimer's disease: relation to apolipoprotein E epsilon 4 allele. , 1996, Journal of neurology, neurosurgery, and psychiatry.

[19]  A. Roses,et al.  Neurodegeneration in the Central Nervous System of apoE-Deficient Mice , 1995, Experimental Neurology.

[20]  M. Mega,et al.  The Neuropsychiatric Inventory , 1994, Neurology.

[21]  J. Morris.  The Clinical Dementia Rating (CDR) , 1993, Neurology.

[22]  N. Maeda,et al.  Generation of mice carrying a mutant apolipoprotein E gene inactivated by gene targeting in embryonic stem cells. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[23]  D. Bennett,et al.  Predictors of behavioral disturbance in Alzheimer's disease. , 1991, Journal of gerontology.

[24]  H. Stampfer,et al.  The Prognosis of Depression in Old Age , 1991, British Journal of Psychiatry.

[25]  R. Mahley,et al.  Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. , 1988, Science.

[26]  F. Mcdowell,et al.  Factors associated with duration of survival in Alzheimer's disease , 1985, Biological Psychiatry.

[27]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[28]  G. Långström,et al.  Dexamethasone Suppression Test and Serum Prolactin in Dementia Disorders , 1983, British Journal of Psychiatry.

[29]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .